This study analyzed health-care data from 510,502 adults aged 55 and over in Scotland1. There were 2,640 people with Parkinson’s disease, who were included in the analysis shown on the image looking at the various comorbidities seen in these people1. Various different physical and mental comorbidity was seen, ranging from constipation that was almost 4-times more common in people with PD compared with controls, to chronic kidney disease that was slightly less common1.
Related content
Overview of three therapeutic strategies targeting alpha-synuclein in the development of disease-modifying treatments for Parkinson’s disease
Graphical representation of how various treatment strategies can impact disease progression in Parkinson’s disease, from symptom relief to potential cure
Illustration of how COMT inhibitors increase dopamine availability in Parkinson’s disease by preventing the breakdown of L-DOPA